Log In
Print
BCIQ
Print
Print this Print this
 

Erythrocyte Encapsulated Adenosine Deaminase (EE-ADA) (OT-81)

  Manage Alerts
Collapse Summary General Information
Company Orphan Technologies Ltd.
DescriptionEnzyme replacement therapy (ERT) comprised of adenosine deaminase encapsulated within autologous erythrocytes
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard Indication Metabolic (unspecified)
Indication DetailsTreat severe combined immunodeficiency (SCID) due to adenosine deaminase deficiency (ADA-SCID)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today